Purpose
To develop, manufacture and conduct clinical testing of a novel nanoparticle displaying a SARS-CoV2 vaccine co-administered with a novel adjuvant.
Grantee
Division
Global Health
Date
SEPTEMBER 2020
Region served
GLOBAL
Committed amount
$9,999,899
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.